Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
作者信息
Epstein M A, Morgan A J
出版信息
Clin Exp Immunol. 1983 Aug;53(2):257-71.
Abstract
摘要
相似文献
1
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
Clin Exp Immunol. 1983 Aug;53(2):257-71.
2
[Epstein-Barr virus infection: immunology and immunopathology].
Ned Tijdschr Geneeskd. 1986 Jan 11;130(2):63-7.
3
Epstein-Barr virus. Is it timely to discuss a vaccine?
Biomedicine. 1978 Jan-Feb;28(1):15-7.
4
[Viruses and human cancers: fundamental aspects and hopes of prevention].
C R Seances Soc Biol Fil. 1986;180(3):249-61.
5
Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
Isr J Med Sci. 1977 Jul;13(7):716-24.
6
The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.
Proc R Soc Lond B Biol Sci. 1984 Mar 22;221(1222):1-20. doi: 10.1098/rspb.1984.0019.
7
[Viral infections of the hematopoietic system: Epstein-Barr-virus and other less characterized viral infections].
Verh Dtsch Ges Pathol. 1981;65:146-51.
8
[Epstein-Barr virus and human cancer].
Recenti Prog Med. 1980 May;68(5):504-42.
9
Evidence for an oncogenic potential of the Epstein-Barr virus.
Cancer Res. 1973 Jun;33(6):1419-23.
10
The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Ann Clin Lab Sci. 1974 Mar-Apr;4(2):109-14.
引用本文的文献
1
EBV-positive human sera contain antibodies against the EBV BMRF-2 protein.
Virology. 2009 Oct 10;393(1):151-9. doi: 10.1016/j.virol.2009.07.025. Epub 2009 Aug 20.
2
Detection of S-100 labelled cells in nasopharyngeal carcinoma.
J Clin Pathol. 1984 Nov;37(11):1235-8. doi: 10.1136/jcp.37.11.1235.
3
Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus.
Clin Exp Immunol. 1984 May;56(2):371-6.
4
S-100 protein positive cells in nasopharyngeal carcinoma (NPC): absence of prognostic significance. A clinicopathological and immunohistochemical study of 40 cases.
Virchows Arch A Pathol Anat Histopathol. 1987;411(3):233-7. doi: 10.1007/BF00735028.
5
Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.
Clin Exp Immunol. 1986 Apr;64(1):65-70.
6
Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
Clin Exp Immunol. 1986 Mar;63(3):485-90.
本文引用的文献
1
The transmission of infectious mononucleosis.
Am J Med Sci. 1955 Mar;229(3):262-72. doi: 10.1097/00000441-195503000-00003.
2
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.
Lancet. 1964 Mar 28;1(7335):702-3. doi: 10.1016/s0140-6736(64)91524-7.
3
Determining the climatic limitations of a children's cancer common in Africa.
Br Med J. 1962 Oct 20;2(5311):1019-23. doi: 10.1136/bmj.2.5311.1019.
4
A children's cancer dependent on climatic factors.
Nature. 1962 Apr 21;194:232-4. doi: 10.1038/194232a0.
5
A sarcoma involving the jaws in African children.
Br J Surg. 1958 Nov;46(197):218-23. doi: 10.1002/bjs.18004619704.
6
Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.
Br J Cancer. 1982 May;45(5):670-8. doi: 10.1038/bjc.1982.107.
7
Malaria and alterations in immune reactivity.
Br Med Bull. 1982 May;38(2):167-72. doi: 10.1093/oxfordjournals.bmb.a071754.
8
Immunity to malaria.
Br Med Bull. 1982 May;38(2):153-9. doi: 10.1093/oxfordjournals.bmb.a071752.
9
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Hepatology. 1981 Sep-Oct;1(5):377-85. doi: 10.1002/hep.1840010502.
10
Burkitt's lymphoma.
N Engl J Med. 1981 Sep 24;305(13):735-45. doi: 10.1056/NEJM198109243051305.
Zotero 插件